February 26, 2021February 24, 2021
A Farewell Note to My Beloved Readers
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
So, the time has come. Here I am, three years after I sat down for the first time to write ... Read more
February 15, 2021February 11, 2021
A Light-giver Shares a Lesson in Emotional Honesty
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Have you ever noticed how the people with the most light to give are often those who have endured the ... Read more
February 1, 2021January 27, 2021
Embarking on a New Chapter While Cherishing the Value of Community
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
It’s surreal to ponder that our world has been living through a pandemic for a year now. That we’ve endured ... Read more
December 14, 2020December 9, 2020
Shedding My Sickness While Acknowledging Its Eternal Impact
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Just before the world changed overnight in March, I wrote a column titled “The Paradox of Healing.” In it, I ... Read more
November 16, 2020November 12, 2020
Sometimes Everything Works Out All Right
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
The other day, I chanced upon a poem called “Sometimes” that stopped me in my tracks and penetrated right through ... Read more
September 28, 2020September 24, 2020
Let’s Not Forget the Superheroes
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Lately, in the midst of all the insanity going on in the world and the ensuing, albeit dispiriting, headlines covering ... Read more
September 14, 2020September 10, 2020
Frozen Toes and Sleepless Nights: The Reality of Being a Cancer Survivor
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
For the past week, I have been living in what I can only describe as a state of unrelenting exhaustion. ... Read more
August 31, 2020August 27, 2020
Can a Break From Routine Induce Healing?
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
This is a question I found myself pondering the other week as I locked up my little flat and escaped ... Read more
August 17, 2020August 13, 2020
Reflections on My ‘Re-birthday’ and the Past Year of Recovery
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
By the time this column is published, the one-year anniversary of my lifesaving stem cell transplant will have come and ... Read more
July 27, 2020July 23, 2020
This Year Has Taught Me Gratitude
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
This week I’ve felt completely at a loss over what to write about. It happens sometimes. Usually there’s something on ... Read more
July 13, 2020July 9, 2020
Total Happiness Is Unobtainable, and That’s OK
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
I recently came to the realization that none of us will ever be totally happy. Upbeat way to start a ... Read more
June 29, 2020June 25, 2020
As I Befriend My Fear of Relapse, Fear Loses Its Power
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Being a cancer survivor is a complicated thing. It’s a lot of conflicting experiences at once. It’s walking down the ... Read more

January 9, 2020January 15, 2020

Venclexta-rituximab Combo Shows Long-term Survival Benefits for Relapsed CLL Patients

News

A combination of Venclexta (venetoclax) and rituximab continues to significantly reduce the risk of disease progression or death in relapsed or refractory chronic lymphocytic leukemia (CLL) patients two years after completing ... Read more

January 7, 2020February 18, 2020

Bristol-Myers Seeks FDA Approval of CAR T-cell Therapy Liso-Cel for Aggressive Large B-cell Lymphomas

News

Bristol-Myers Squibb has asked the U.S. Food and Drug Administration (FDA) to approve its investigational CAR T-cell therapy lisocabtagene maraleucel (liso-cel) for people with large B-cell lymphoma who received at ... Read more

January 7, 2020February 14, 2020

FDA Grants Orphan Drug Status to CLR 131 for Lymphoplasmacytic Lymphoma Treatment

News

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Cellectar BioSciences‘ experimental therapy CLR 131 for lymphoplasmacytic lymphoma (LPL), or Waldenström’s macroglobulinemia, a rare type of ... Read more

January 2, 2020January 2, 2020

Revlimid-Rituximab Combo Approved in Europe for Previously Treated Follicular Lymphoma

News

The European Commission has approved Bristol-Myers Squibb‘s Revlimid (lenalidomide) in combination with rituximab to treat adults with follicular lymphoma who are no longer responding to other therapies. The combination is the first chemotherapy-free treatment ... Read more

December 17, 2019December 20, 2019

Meeting with FDA Supports Tazemetostat for Some Follicular Lymphoma

News

Epizyme successfully met with the U.S. Food and Drug Administration (FDA) to bolster an upcoming submission of its oral investigational treatment tazemetostat for relapsed or resistant follicular lymphoma, with or ... Read more

December 12, 2019December 12, 2019

Health Canada Approves Adcetris-Chemo Combo for Initial Peripheral T-cell Lymphoma Treatment

News

Health Canada has expanded its approval of Adcetris (brentuximab vedotin) in combination with a chemotherapy regimen for the first-line treatment of peripheral T-cell lymphomas expressing the CD30 marker. The approval is ... Read more

December 9, 2019December 19, 2019

Imbruvica Extends Time to Disease Worsening over Prior Regimen in MCL, Data Shows

News

The time to disease worsening or death usually shortens with each additional line of therapy, but that does not seem to be the case when the Bruton’s tyrosine kinase (BTK) inhibitor ... Read more

December 9, 2019December 5, 2019

Lighter Days Are Around the Corner

Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman

“Oh, by the way,” she said nonchalantly as I entered the room. “Your scans are clear.” “I’m sorry, what?” I stuttered in disbelief. Just like that, in a matter of ... Read more

December 5, 2019

CHMP Favors Revlimid-Rituximab Combo for Advanced Follicular Lymphoma Patients in EU

News

A branch of the European Medicines Agency voiced support for Revlimid (lenalidomide) in combination with rituximab becoming a treatment option for adults with follicular lymphoma who responded poorly to, or whose disease returned ... Read more

December 5, 2019December 10, 2019

Orencia Given FDA’s Breakthrough Status as Treatment to Prevent Graft-versus-Host Disease After Stem Cell Transplant

News

Bristol-Myers Squibb‘s arthritis medicine Orencia (abatacept) has been named Breakthrough Therapy by the U.S. Food and Drug Administration for the prevention of acute graft-versus-host disease (GvHD) in patients who received ... Read more

November 26, 2019November 26, 2019

FDA Approves Calquence as Treatment Option for Adults with CLL and SLL

News

The U.S. Food and Drug Administration (FDA) has approved AstraZeneca’s Calquence (acalabrutinib) to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The agency’s decision was based ... Read more

November 22, 2019November 22, 2019

EU Advisory Committee Favors Approval of Polivy with MabThera and Bendamustine for Advanced DLBCL

News

An advisory committee for the European Medicines Agency has recommended the conditional approval of Roche‘s Polivy (polatuzumab vedotin) in combination with MabThera (rituximab) and bendamustine (a chemotherapy) for the treatment of ... Read more

A Farewell Note to My Beloved Readers

A Light-giver Shares a Lesson in Emotional Honesty

Embarking on a New Chapter While Cherishing the Value of Community

Shedding My Sickness While Acknowledging Its Eternal Impact

Sometimes Everything Works Out All Right

Let’s Not Forget the Superheroes

Frozen Toes and Sleepless Nights: The Reality of Being a Cancer Survivor

Can a Break From Routine Induce Healing?

Reflections on My ‘Re-birthday’ and the Past Year of Recovery

This Year Has Taught Me Gratitude

Total Happiness Is Unobtainable, and That’s OK

As I Befriend My Fear of Relapse, Fear Loses Its Power